Intriguingly, suppressing P2 × 7R with an antagonist or shRNA promotes cell growth through the up-regulation of EGFR, p-EGFR, HIF-1α, and VEGF in glioma cells (Fang et al., 2013). The gene discussed is HIF1A; the disease is central nervous system cancer.